---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-009895"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2024-03-14T23:59:59+00:00"
generated_at: "2026-06-04T21:27:52.011963+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics completes $18.16M Series B Preferred offering and exchange of Series A/A-1 shares

## Summary
- Gross proceeds of $18.16M: $12.495M from new subscriptions and $5.67M from Series A-1 sales immediately exchanged.
- Series B Preferred convertible at $1.2444 per share; mandatory conversion on Mar 13, 2026 or if VWAP >$8 for 20 of 30 days.
- Annual dividends: 20% of conversion shares on Mar 13, 2025 and Mar 13, 2026; accelerated on fundamental transactions.
- Beneficial ownership limited to 4.99% (or 9.99% at holder election); primary market cap of 19.99% of outstanding common.
- All outstanding Series A and A-1 Preferred exchanged; 44,285 Series B shares outstanding after close.

## SEC filing metadata
- accession: 0001493152-24-009895
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2024-03-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.02, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000149315224009895/0001493152-24-009895-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000149315224009895/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-009895
- JSON: https://secwatch.observer/filing/0001493152-24-009895.json
- Plain text: https://secwatch.observer/filing/0001493152-24-009895.txt

## Key facts
- Governance Changes
  Lucid Diagnostics Inc.: 公司修订了公司章程，授权发行最多20,000,000股优先股，并通过系列B指定证书和系列A-1修订证书分别指定了系列B优先股和增加系列A-1优先股数量。.
  - Change: charter amendment
  source text: The Amended and Restated Certificate of Incorporation of the Company authorizes the issuance of up to 20,000,000 shares of preferred stock, par value $0.001 per share, and further authorizes the Board of the Company to fix and determine the designation, preferences, conversion rights, or other rights, including voting rights, qualifications, limitations, or restrictions of the preferred stock. The Series B Certificate of Designation designates up to 56,000 of the shares of preferred stock as Series B Preferred Stock and the Series A-1 Certificate of Amendment increases the number of shares designated as Series A-1 Preferred Stock by 5,670 shares.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799011/000149315224009895/0001493152-24-009895-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.